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Background: The sorting nexin (SNX) family is involved in endocytosis and protein trafficking and plays multiple
roles in various diseases. The role of SNX proteins in Kawasaki disease (KD) is not known. We attempted to test
whether genetic SNX variation associates with the risk of coronary artery aneurysm (CAA) formation in KD.
Methods and results: Chi-square tests were used to identify SNX24 genetic variants associated with KD
susceptibility and CAA formation in KD; models were adjusted for fever duration and time of first administration of
intravenous immunoglobulin. We obtained clinical characteristics and genotypes from KD patients (76 with CAA
and 186 without CAA) in a population-based retrospective KD cohort study (n = 262). Clinical and genetic factors
were associated with CAA formation in KD. In addition, endothelial cell inflammation was evaluated. Significant
correlation was observed between KD with CAA complications and the rs28891 single-nucleotide polymorphism in
SNX24. Patients with CC + CT genotypes had lesser CAA complications. In lipopolysaccharide-treated human
umbilical vein endothelial cells, siRNA knockdown of SNX24 significantly decreased gene expression of the
proinflammatory cytokines IL-1 beta, IL-6, and IL-8.
Conclusions: Polymorphisms in SNX24 may be used as genetic markers for the diagnosis and prognosis of CAA
formation in KD.
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Kawasaki disease (KD) is an acute and systemic vascu-
litis in children under 5 years old [1-5]. It is believed to
be caused by infectious agents, host immune dysregula-
tion, and genetic susceptibility. During the acute stage of
KD, activation of vascular endothelial cells and increased
serum levels of proinflammatory cytokines lead to in-
flammation and injury of blood vessels [6-8]. The vascu-
lar inflammation may induce the development of
aneurysms and cardiac complications. Complications in
coronary artery aneurysms (CAA) make KD one of the
leading causes of acquired cardiovascular diseases in* Correspondence: yjlin.kath@gmail.com; d0704@mail.cmuh.org.tw
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reproduction in any medium, provided the orchildhood. Until now, the pathological mechanism of
CAA formation in KD has not been fully elucidated.
The sorting nexin (SNX) family of proteins consists of a
diverse group of cytoplasmic or membrane-associated mol-
ecules that are characterized by the presence of a
phospholipid-binding motif, the phox-homology (PX) do-
main, and are involved in endocytosis and protein traffick-
ing [9,10]. The presence of a PX domain is the defining
characteristic of this family and has been shown to bind
various phosphatidylinositol phosphates (PtdInsPs) [11,12].
This domain is thought to lead these proteins to specialized
membrane domains with specific phospholipids [13]. Sort-
ing nexins have been associated with various diseases, in-
cluding tumorigenesis, inflammation, pathogen infection,
and Alzheimer disease [14-19]. The role of SNX proteins
in endothelial cell injury and inflammation and their. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Lin et al. Cell & Bioscience 2013, 3:44 Page 2 of 10
http://www.cellandbioscience.com/content/3/1/44correlation with cardiovascular diseases such as KD remain
to be elucidated.
To this end, we screened variants of 10 genes that en-
code SNX proteins associated with KD with CAA forma-
tion. The genes studied were SNX17, SNX3, SNX10,
SNX16, SNX22, SNX29, SNX20, SNX11, SNX21, and
SNX24. In this study, 262 KD patients (76 with CAA
and 186 without CAA) were evaluated for clinical char-
acteristics, the extent of aneurysm formation, and
SNX24 genotype. We observed that genetic variation in
SNX24 was associated with CAA formation in KD.
Results
Genotype frequencies of SNX24 polymorphisms
A total of 262 KD patients and 1107 unrelated healthy
control individuals were included in this study. TheTable 1 Genotype distributions of SNX24 gene SNPs in Taiwa
SNP Chromosome Cytoband Physical position Nearest g
rs154507 5 q23.2 122228806 SNX2
rs27740 5 q23.2 122232671 SNX2
rs26371 5 q23.2 122234424 SNX2
rs6595415 5 q23.2 122234657 SNX2
rs17149732 5 q23.2 122249811 SNX2
rs17149748 5 q23.2 122295266 SNX2
rs1038078 5 q23.2 122309550 SNX2
rs28891 5 q23.2 122311523 SNX2
rs6595423 5 q23.2 122341433 SNX2
SNX24, sorting nexin 24; SNP, single nucleotide polymorphism; CI, confidence interv
p-values were obtained by chi-square test.
Bold, emphasizing statistical significance was considered as p value <0.006 (0.05/9).genotypes of the 9 genetic polymorphisms were identi-
fied by a custom-designed genotyping method [20]. The
genotype frequencies of these polymorphisms are shown
in Table 1. The KD patients did not differ from the con-
trol individuals with respect to the genotype frequencies
of these polymorphisms (Table 1).
SNX24 single-nucleotide polymorphism rs28891 is associ-
ated with CAA formation in KD
Subsequently, we genotyped the 262 KD patients
for SNX24 single-nucleotide polymorphisms (SNPs)
(Table 2). The genetic location of SNX24 is shown in
Figure 1; the frequency of genotyping success was >99%.
The linkage disequilibrium (LD) structure of this region
was also established and was found to consist of a single
haplotype block.nese KD patients and controls
enes Controls KD patients
No. (%) No. (%) p value Odds ratio (95% CI)
4 GG 146 (13.2) 38 (14.5) 0.755 1.17 (0.76–1.78)
GC 553 (50.0) 133 (50.8) 1.08 (0.80–1.45)
CC 408 (36.8) 91 (34.7) 1
4 TT 156 (14.1) 38 (14.5) 0.867 1.08 (0.71–1.65)
TA 547 (49.4) 133 (50.8) 1.08 (0.80–1.45)
AA 404 (36.5) 91 (34.7) 1
4 TT 217 (19.6) 56 (21.4) 0.690 1.19 (0.80–1.76)
TC 573 (51.8) 137 (52.3) 1.10 (0.80–1.51)
CC 317 (28.7) 69 (26.3) 1
4 TT 151 (13.6) 38 (14.5) 0.842 1.12 (0.73–1.70)
TC 530 (47.9) 128 (48.9) 1.07 (0.80–1.44)
CC 426 (38.5) 96 (36.6) 1
4 TT 146 (13.2) 37 (14.1) 0.784 1.14 (0.74–1.73)
TG 530 (47.9) 129 (49.2) 1.09 (0.81–1.46)
GG 430 (38.9) 96 (36.6) 1
4 CC 150 (13.6) 37 (14.1) 0.710 1.13 (0.74–1.72)
CT 532 (48.1) 131 (50.0) 1.13 (0.84–1.51)
TT 425 (38.4) 93 (35.5) 1
4 AA 147 (13.3) 37 (14.1) 0.676 1.15 (0.75–1.76)
AG 526 (47.5) 130 (49.6) 1.13 (0.84–1.51)
GG 434 (39.2) 95 (36.3) 1
4 CC 187 (16.9) 47 (17.9) 0.836 1.12 (0.75–1.67)
CT 554 (50.1) 133 (50.8) 1.07 (0.79–1.45)
TT 366 (33.1) 82 (31.3) 1
4 CC 144 (13.0) 36 (13.7) 0.667 1.14 (0.75–1.75)
CT 524 (47.3) 130 (49.6) 1.13 (0.85–1.52)
TT 439 (39.7) 96 (36.6) 1
al.
Table 2 Summary of the SNPs associated with the CAA formation in Taiwanese Kawasaki disease
SNP Chromosome Cytoband Physical position Nearest genes CAA- CAA+
No. (%) No. (%) p value Odds ratio (95% CI)
rs154507 5 q23.2 122228806 SNX24 GG 24 (12.9) 14 (18.4) 0.234 1.94 (0.86–4.41)
GC 92 (49.5) 41 (54.0) 1.49 (0.81–2.74)
CC 70 (37.6) 21 (27.6) 1
rs27740 5 q23.2 122232671 SNX24 TT 24 (12.9) 14 (18.4) 0.234 1.94 (0.86–4.41)
TA 92 (49.5) 41 (54.0) 1.49 (0.81–2.74)
AA 70 (37.6) 21 (27.6) 1
rs26371 5 q23.2 122234424 SNX24 TT 44 (23.7) 12 (15.8) 0.123 0.45 (0.20–1.01)
TC 99 (53.2) 38 (50.0) 0.63 (0.34–1.17)
CC 43 (23.1) 26 (34.2) 1
rs6595415 5 q23.2 122234657 SNX24 TT 23 (12.4) 15 (19.7) 0.198 2.07 (0.93–4.61)
TC 90 (48.4) 38 (50.0) 1.34 (0.73–2.45)
CC 73 (39.2) 23 (30.3) 1
rs17149732 5 q23.2 122249811 SNX24 TT 23 (12.4) 14 (18.4) 0.261 1.93 (0.86–4.36)
TG 90 (48.4) 39 (51.3) 1.38 (0.75–2.51)
GG 73 (39.2) 23 (30.3) 1
rs17149748 5 q23.2 122295266 SNX24 CC 23 (12.4) 14 (18.4) 0.242 1.96 (0.87–4.45)
CT 91 (49.2) 40 (52.6) 1.42 (0.77–2.60)
TT 71 (38.4) 22 (29.0) 1
rs1038078 5 q23.2 122309550 SNX24 AA 23 (12.4) 14 (18.4) 0.283 1.91 (0.84–4.30)
AG 91 (48.9) 39 (51.3) 1.34 (0.74–2.45)
GG 72 (38.7) 23 (30.3) 1
rs28891 5 q23.2 122311523 SNX24 CC 39 (21.0) 8 (10.6) 0.006 0.29 (0.12–0.70)
CT 99 (53.2) 34 (44.7) 0.48 (0.27–0.87)
TT 48 (25.8) 34 (44.7) 1
rs6595423 5 q23.2 122341433 SNX24 CC 23 (12.4) 13 (17.1) 0.322 1.79 (0.79–4.10)
CT 90 (48.4) 40 (52.6) 1.41 (0.78–2.57)
TT 73 (39.2) 23 (30.3) 1
SNX24, sorting nexin 24; SNP, single nucleotide polymorphism; CAA, Coronary artery aneurysm; CI, confidence interval.
p-values were obtained by chi-square test.
Bold, emphasizing statistical significance was considered as p value <0.05.
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shown in Table 2. A statistically significant difference was
observed for the SNX24 (rs28891) genetic variant (p =
0.006). The frequencies of individuals carrying the CC and
CT genotypes of SNX24 (rs28891) were 10.6% and 44.7%,
respectively, for CAA-positive individuals. The frequencies
of the CC and CT genotypes were significantly lower in KD
individuals with CAA formation (CC genotype: odds ratio
(OR) = 0.29, 95% confidence interval (CI) = 0.12–0.70; CT
genotype: odds ratio = 0.48, 95% CI = 0.27–0.87) compared
to KD individuals without CAA formation.
Associating variation in the SNX24 SNP rs28891 to CAA
formation in KD by using logistic regression analysis
To determine the genetic role of SNX24, we used logistic
regression analysis to rule out the clinical potentialfactor effects in CAA formation in KD. As shown in
Table 3, after adjusting for these factors [21-25], there
was a significant association between the SNX24 SNP
rs28891 and the incidence of KD with CAA. Specifically,
significant correlations were found between KD with
CAA formation and the CC + CT genotypes of the
SNX24 SNP rs28891 (model adjusted by fever duration:
odds ratio = 0.41, 95% CI = 0.25–0.75, p = 0.003; model
adjusted by time of first administration of in-
travenous immunoglobulin (IVIG): odds ratio = 0.42,
95% CI = 0.25–0.75, p = 0.002).
The genotype distributions of rs28891 in relation to
CAA severity in the study population are also shown in
Figure 2. As shown in Figure 2, there were lower per-
centages of the SNX24 SNP genotypes CC + CT in pa-
tients with CAA formation compared to patients with
SNX24
Chr 5 122 M 123 M
122290 K122230 K 122340 K
Figure 1 Analysis of the single-nucleotide polymorphisms (SNPs) used in this study, and the linkage disequilibrium (LD) pattern of the
SNX24 gene. The genomic location of SNPs present on chromosome 5q23.2. LD blocks in the SNX24 gene were estimated by using HAPLOVIEW.
Pairwise D’ values (%, n = 27) are indicated in squares; red indicates linkage disequilibrium (D’ = 1, logarithm of odds (LOD)≥ 2).
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CT genotypes were correlated with less severe CAA
complications.
Inhibition of IL-1 beta, IL-6, and IL-8 mRNA expression by
downregulation of SNX24 in lipopolysaccharide-treated
human umbilical vein endothelial cells
To evaluate the effect of SNX24 on endothelial cell in-
flammation, we used lipopolysaccharide (LPS) (an inte-
gral part of the outer membrane of gram-negative
bacteria) as a pathogenic stimulus. Human umbilical
vein endothelial cells (HUVECs) were transfected with
short interfering RNAs (siRNAs) and then were treated
with LPS. The proinflammatory cytokine expression in
the endothelial cells was then analyzed by using real-
time qPCR assays (Figure 3). HUVECs were transiently
transfected with siRNAs targeting SNX24 (siSNX24),
and the effect was assessed (Figure 3A). Compared to
siNC-transfected HUVECs, cells transfected with
siSNX24 resulted in a significant decrease in SNX24
mRNA expression (Figure 3A). In addition, siRNA-
transfected cells were then exposed to LPS. As shown in
Figure 3B, treatment of HUVECs with LPS significantly
increased the expression of IL-1 beta, IL-6, and IL-8.
siRNA knockdown of SNX24 significantly decreased
gene expression of the proinflammatory cytokines IL-1
beta, IL-6, and IL-8, suggesting that SNX24 may regulate
endothelial cell inflammation.Discussion
To the best of our knowledge, no study to date has in-
vestigated the possible association of SNX family genes
and the CAA formation in Kawasaki disease. In this
study, we screened genetic variants of 9 SNX genes in
relation to KD with CAA formation and identified a
SNP in SNX24 that correlates with the development of
CAA formation in Taiwanese children of Han Chinese
ethnic background with KD. We observed a significant
association between the SNX24 SNP and the occurrence
of CAA in KD patients by using a logistic regression
analysis. The frequencies of the CC and CT genotypes of
SNX24 SNP rs28891 were lower in the group with KD
and CAA than in the group with KD but without CAA.
Cell inflammatory activity was inhibited in siSNX24-
treated cells. Our results suggest that polymorphisms in
SNX24 may be used as genetic markers for the diagnosis
and prognosis of the CAA formation in KD.
Our results showed that the increased CAA formation
in KD was associated with clinical risk factors, including
fever duration and the time of administering the first
IVIG treatment (days after the first incidence of fever).
These findings also correspond with those reported pre-
viously in patients with KD [21-25]. Longer fever dur-
ation and the delay of IVIG treatment seem to be risk
factors for the development of CAA in patients with KD.
Prolonged fever duration suggests a state of longer and
more severe inflammation. Endothelial cell injury and
Table 3 Association of SNX24 genetic variants with CAA formation risk in Taiwanese Kawasaki disease by logistic
regression analysis
SNX24 genetic variants Odds ratio 95% CI p value
Adjusted by fever duration (days)
rs154507 1.90 0.88-2.83 0.046
rs27740 1.90 0.88-2.83 0.046
rs26371 0.60 0.32-1.04 0.105
rs6595415 1.74 0.84-2.64 0.077
rs17149732 1.74 0.84-2.64 0.077
rs17149748 1.83 0.86-2.72 0.057
rs1038078 1.71 0.82-2.58 0.087
rs28891 0.41 0.25-0.75 0.003
rs6595423 1.74 0.84-2.64 0.077
Adjusted by 1st IVIG used (days after the first date with fever)
rs154507 1.61 0.88-2.83 0.114
rs27740 1.61 0.88-2.83 0.114
rs26371 0.57 0.32-1.04 0.059
rs6595415 1.52 0.84-2.64 0.152
rs17149732 1.52 0.84-2.64 0.152
rs17149748 1.57 0.86-2.72 0.127
rs1038078 1.50 0.82-2.58 0.171
rs28891 0.42 0.25-0.75 0.002
rs6595423 1.52 0.84-2.64 0.152
SNX24, sorting nexin 24; IVIG, Intravenous immunoglobulin; CAA, Coronary artery aneurysm; CI, confidence interval.
A logistic regression model was performed by using the indicated predictors including fever duration (days) or 1st IVIG used time (days after the first date
with fever).







































Figure 2 Genotype distribution (SNX24 rs28891) in relation to coronary artery aneurysm (CAA) severity in the study population. CAA
severity grade: CAA- indicates patients with no complication; CAA + B grade indicates patients with CAAs at the beginning but that are in remis-
sion within 2 months; CAA + C grade indicates patients with CAAs that persist for 2 months but that are in remission within 6 months; CAA + D
grade indicates patients with CAAs that persist for 6 months; CAA + E grade indicates patients with giant CAAs (≥8 mm) or severe stenosis
or occlusion.

























Figure 3 Effect of SNX24 knockdown on proinflammatory
cytokines. HUVECs were transfected with siSNX24 or siNC for 24 h
at 37°C followed by 100 μg/mL LPS for another 24 h. A. siSNX24
knockdown efficacy in HUVECs by using RT-qPCR assay. B. IL-1 beta,
IL-6, and IL-8 mRNA expression was quantified by RT-qPCR. * p < 0.05
versus siNC + LPS. Data represent mean ± SD for 3 independent
experiments.
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the development of KD [4]. When endothelial cells are
stimulated with pathogenic mediator LPS, inflammatory
signals are triggered, which increase permeability and
leukocyte recruitment [26]. KD is a multi-systemic dis-
order with immune-mediated vasculitis and is very likely
to influence CAA complications.
This genetic association study showed that significant
associations between KD with CAA formation and the
SNX24 SNP rs28891 were still observed by using logisticregression analysis. The frequency of genotypes with 1
or 2 copies of the C allele were lower in KD patients
with CAA formation. This SNP is located in the intron
region of SNX24. Intronic SNPs may have an impact on
splicing efficiency, the stability of the transcribed mRNA,
and enhancer activity [27]. Change in the secondary
structure of the pre-mRNA by a nucleotide substitution
may influence splicing and mRNA formation [28,29]. In
addition, the SNP we identified (rs28891) exhibited LD
with the SNP (rs1038078) (Additional file 1: Table S1;
D’ = 1). SNX24 expression has been shown to be signifi-
cantly associated with the SNP (rs1038078) (p = 0.04329)
in the Han Chinese population (http://app3.titan.uio.no/
biotools/tool.php?app=snpexp). Therefore, it is likely
that the CC and CT genotypes of the SNX24 gene poly-
morphism may be associated with transcript abundance.
To further investigate the functional consequences of
SNX24 polymorphism, we first investigated the correl-
ation between the SNP rs28891 genotypes and SNX24
expression (Additional file 2: Figure S1). We measured
SNX24 mRNA levels by real-time quantitative PCR in
peripheral blood mononuclear cells. As shown, the
major allele homozygotes (TT genotype) tended to ex-
press higher levels of SNX24 than did the other individ-
uals with CC + CT genotype (p = 0.035; Additional file 2:
Figure S1). Our results also suggest that the frequencies
of CC and CT genotypes were significantly lower in KD
with CAA formation compared to those in KD without
CAA formation. A possible explanation is that the
SNX24 protein expression levels are involved in inflam-
mations of vascular endothelial cells and the conse-
quences of CAA complications in KD patients.
Endothelial cell injury and inflammations are known
to be the main mechanisms in the development of KD
[4]. When endothelial cells are stimulated with patho-
genic mediator LPS, the stimulated cells trigger inflam-
matory signals to increase permeability and leukocyte
recruitment [26]. In this study, we used this LPS-
induced endothelial cell inflammation model and
showed, for the first time, that SNX24 may regulate
endothelial cell inflammation by interfering with IL-1
beta, IL-6, and IL-8 expressions. SNX24 is located on
chromosome 5q23.2. It is preferentially expressed in
platelets and blood plasma (http://www.genecards.org/cgi-
bin/carddisp.pl?gene=SNX24&search=SNX24#diseases).
Estrogen has been found to significantly upregulate the ex-
pression of SNX24 in certain breast cancer cell lines, sug-
gesting that it has a role in tumorigenesis [30]. Conversely,
SNX family proteins have been linked to trafficking and cell
surface presentation of adhesion molecules on leucocytes,
platelets, and endothelial cells. SNX family proteins might
be involved in vasculitis and endothelial cell pathogenesis.
Another member in the SNX family, SNX17, was identified
as a P-selectin-interacting protein. It can decrease the
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transport into late endosomes, thereby affecting leucocyte
recruitment [15,31]. The release of chemokines and cyto-
kines by macrophages within injured tissue will initiate a
series of events whereby leucocytes are attached to the
endothelium [32,33].
We screened genetic variants of 9 genes that encode
SNX genes linked to KD with CAA formation (Additional
file 1: Table S1). These genes include SNX17, SNX3,
SNX10, SNX16, SNX22, SNX29, SNX20, SNX11, and
SNX21. This gene family encodes proteins that belong
to a diverse group of cytoplasmic and membrane-
associated proteins and are involved in various aspects
of endocytosis and protein trafficking through mem-
branous cellular compartments [9]. No significant statis-
tical difference was observed for these SNX genes with
respect to KD with CAA formation. We only observed a
significant association between KD with CAA formation
and the SNX24 (rs28891). Therefore, we suggest that this
SNX24 genetic variant has a role in CAA formation in
KD patients. In addition, in our study of the functional
significance of SNX24 in endothelial cell inflammation,
we used siRNA knockdown of SNX24 to significantly de-
crease gene expression of the proinflammatory cytokines
of IL-1 beta, IL-6, and IL-8. This is the first study to re-
port that SNX24 is a regulator of vascular inflammation
and may be beneficial for many inflammatory diseases
associated with endothelial dysfunction.
Methods
Study subjects
Unrelated individuals fulfilling the diagnostic criteria of KD
(n = 262) were identified and enrolled in the study from the
Department of Pediatrics at China Medical University Hos-
pital in Taichung, Taiwan [21,34-37]. All patients were diag-
nosed according to KD criteria [21,35], including fever
lasting 5 days or more and at least 4 of the following symp-
toms: (1) changes in extremities (e.g., erythema, edema, or
desquamation), (2) bilateral conjunctivitis, (3) polymorph-
ous rash, (4) cervical lymphadenopathy, and (5) changes in
the lips or oral cavity (e.g. pharyngeal erythema, dry/
fissured or swollen lips, or “strawberry tongue”). All patients
received IVIG treatment and had regular echocardiographic
examinations during the 1-year follow-up. The echocardio-
graphic examinations were made during the acute stage,
2 months after onset, 6 months after onset, and once per
year thereafter. CAA was identified when either the right or
the left coronary artery showed a dilated diameter ≥3 mm
in children younger than 5 years of age, or ≥4 mm in older
children [38]. Only Han Chinese individuals, who account
for 98% of Taiwanese residents, were recruited. The ethnic
background was assigned based on the results of self-
reported questionnaires. This study was approved by the
Human Studies Committee of China Medical UniversityHospital. Written informed consent was obtained from ei-
ther the parents or the participants.
SNP genotyping
Nine SNPs located in SNX24 were randomly selected from
the identified candidate SNPs that conformed to a set of
criteria, by using the HAPLOVIEW software (Figure 1 and
Table 2) [39-41]. The selection criteria that were used in-
cluded a minimum allele frequency of p > 0.05 in the Han
Chinese population, and no deviation from HWE (p > 0.05).
A summary of information regarding the SNX24 SNPs (lo-
cation, position, rs number, and genotype) is listed in
Table 2. Briefly, genomic DNA was extracted from periph-
eral blood leukocytes according to standard protocols
(Genomic DNA kit; Qiagen, Hilden, Germany). SNPs were
genotyped using a custom-designed VeraCode GoldenGate
Genotyping Assay System (Illumina, San Diego, CA, USA)
[42]; genotyping was performed as described at http://www.
illumina.com/.
Primers and probes were designed using the Custom
VeraCode GoldenGate Genotyping Assay System soft-
ware. Multiplex PCRs were performed with 144-plex
VeraCode SNP arrays (Illumina) using these samples,
and genotype analyses were performed using custom 96-
plex SAM arrays for 96 samples. Genotype calls were
automatically generated using GenCall version 3.1.3. We
assessed 8 VeraCode runs individually for intra-plate in-
consistencies, such as variation in the intensity of the
fluorescence. Genotype cluster plots generated from in-
dividual VeraCode and SAM assays were visually
inspected for call quality. Plots that appeared to be “un-
usually” clustered (i.e., those that did not match the pre-
dicted spread in terms of software-generated HWE or
distance between clusters [θ]) were investigated further
by confirming the genotype of the selected samples via
direct Sanger sequencing. Samples were sequenced using
Big Dye Terminator v3.1 (AB, Foster City, CA, USA)
according to the manufacturer’s guidelines and se-
quenced using a 3730 genetic analyzer (Life Technolo-
gies, Carlsbad, CA, USA).
Analysis of haplotype blocks
Based on HAPLOVIEW, we used Lewontin’s D’ to esti-
mate the inter-marker coefficient of LD of patients [41].
The confidence interval of LD was estimated using a re-
sampling procedure and was used to construct haplotype
blocks [43,44].
Statistical analysis
Unless otherwise indicated, data are expressed as the mean±
SD for continuous variables. The unpaired Student’s t test
was used to compare groups. Genotypes were obtained by
direct counting followed by allele frequency calculations
(Table 2). Chi-squared tests were used to identify
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were calculated for the factors under consideration. For-
ward stepwise multivariate regression analyses were also
performed to identify factors contributing independently
to CAA formation in KD. All statistical analyses were per-
formed using SPSS v12.0 for Windows (IBM, Armonk,
NY, USA).
Cells
HUVECs (BCRC Number: H-UV001) were grown in 90%
GIBCO medium 199 (Life Technologies) with 25 U/mL
heparin (Sigma), 30 μg/mL endothelial cell growth supple-
ment (Millipore) adjusted to contain 1.5 g/L sodium bicar-
bonate + 10% fetal bovine serum and 100 U/mL penicillin/
streptomycin.
Short interfering RNA
siRNAs targeting transcripts for SNX24 (siSNX24:
CAGAAAUCCCUUCUAAACAUGUUAG) were pur-
chased from Invitrogen, as was the non-targeting siRNA
control (scrambled (siNC: duplex 1, AUGAACGU
GAAUUGCUCAA; duplex 2, UAAGGCUAUGAAGA
GAUAC; duplex 3, AUGUAUUGGCCUGUAUUAG;
duplex 4, UAGCGACUAAACACAUCAA)).
Endothelial cell inflammation assay
For endothelial cell inflammation assay, HUVECs were
aliquoted in 6-well plates. Cells were transfected by ei-
ther siNC or siSNX24 using Lipofectamine 2000 (Invi-
trogen). The transfected cells were then treated with
100 μg/mL LPS for another 24 h. Cellular RNA extrac-
tion and real-time RT-PCR analyses were performed.
Real-time RT-PCR analyses
HUVECs transfected by either siNC or siSNX24 were incu-
bated for 36 h at 37°C. Cellular RNA isolation was per-
formed using a QIAamp® RNA Mini Kit according to the
manufacturer’s instructions (Qiagen, Valencia, CA, USA).
RNA was eluted in 60 μL of buffer, and real-time TaqMan
RT-PCR assays were used to determine the effects of
siSNX24 knock down. The primers used to amplify SNX24
by qPCR were 5′ forward primer: 5′-CGTCCTTTCGCTA
TGAAGAGA-3′ and 3′ reverse primer: 5′-TTCTTCC
ATTCATTAGCACTTCTATC-3′. The primers for IL-1
beta qPCR were 5′ forward primer: 5′-tacctgtcctgcgtgttgaa-
3′ and 3′ reverse primer: 5′-tctttgggtaatttttgggatct-3′. The
primers for IL-6 qPCR were 5′ forward primer: 5′-cag
gagcccagctatgaact-3′ and 3′ reverse primer: 5′-gaaggcag
caggcaacac-3′. The primers for IL-8 qPCR were 5′ forward
primer: 5′-gagcactccataaggcacaaA-3′ and 3′ reverse primer:
5′-atggttccttccggtggt-3′. Reverse transcription was per-
formed in a 10-μL reaction mixture consisting of 2 μL
RNA template, 1 μL RT primer mix, 1 μL dNTP mix
(10 mM of each), and 6 μL of RNA/DNAse-free water, at65°C for 5 min. Next, a reaction mixture of 4 μL 5× MMLV
buffer, 0.8 μL MMLV enzyme, and 5.2 μL RNA/DNAse-free
water was added to each RNA sample. Reverse tran-
scription reactions were performed at 42°C for 60 min.
cDNA was amplified by PCR in a 20-μL reaction mixture
containing 5 μL cDNA, 10 μL, 2× Mastermix, 1 μL primer/
probe mix, and 4 μL RNA/DNAse-free water. Real-time
TaqMan RT-PCR conditions were 95°C for 10 min, 50 cy-
cles of 95°C for 10 s, and 60°C for 60 s. SNX24 RNA levels
were detected using a 7900HT Fast Real-Time PCR System
(Life Technologies).
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Additional file 1: Table S1. Summary of the SNPs from SNX gene
family associated with the CAA formation in Taiwanese Kawasaki disease.
Table S2. Haplotype distributions of SNX24 gene SNPs associated with
the CAA formation in Taiwanese KD patients. Table S3. Genotype
distributions of SNX24 gene SNPs in Taiwanese male and female KD
patients. Table S4. Genotype distributions of SNX24 gene SNPs in
Taiwanese male KD patients. Table S5. Genotype distributions of SNX24
gene SNPs in Taiwanese female KD patients.
Additional file 2: Figure S1. SNX24 mRNA expression levels in
peripheral blood mononuclear cells between the SNX24 SNP (rs28891)
genotypes. The relative SNX24 expression was detected by real-time
RT-PCR, and expression from individuals with CC + CT genotypes was
compared to that from individuals with TT genotypes. The relative expression
levels were expressed as SNX24 mRNA/ HPRT mRNA ratio. Figure S2.
Single nucleotide polymorphisms (SNPs) of the SNX24 gene used in this
study. Above and middle: Genomic location of SNPs present on chromosome
5. Down: Non-coding RNAs mapped to the intron 3 of SNX24 gene.
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